Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial
Recruiting · NCT07206199 · Interventional (participants receive a specific treatment) · Lead sponsor: National Institute of Mental Health, Czech Republic
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-subject design for comparison. Patients first complete informed consent and baseline questionnaires and are placed on a waiting list for five weeks. After this period, they are reassigned to the active (experimental) group, which will receive five sessions of exposure therapy in virtual reality over a subsequent five-week period. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.
Who can take part
Inclusion criteria
- Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11
- Fluent in Czech
Exclusion criteria
- Any other psychiatric, neurological and serious somatic illness
- Substance abuse
- Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics.
- Contradictions to using a virtual reality (e.g., epilepsy, balance problems)
- Pregnancy
- Cardiostimulator and mental implants
Where it is running
1 location listed.
- Nationa Institute of Mental Health - Klecany, Česká Republika, Czechia